News

Australian study flags immune resistance in phage therapy treatment

The results from the first VICPhage case highlighted implications for future clinical design.

Hospital networks to drive 6.8% annual growth in digital medical partnerships

Asia Pacific is expanding through public health digitisation, amongst others.

Duke-NUS to build wastewater disease early warning system with $2.3m grant

It is a cost-effective approach to monitoring disease at the community level.

DEE market to surge almost 12% annually on gene therapy advances

Patient pool rises to 326,000 by 2036 across 7MM as diagnosis rates increase.

New Zealand oncology unit cuts travel time for northland patients

It is expected to treat around 370 patients each year initially.

AI in healthcare market targets massive growth as data volumes surge

Asia Pacific is expected to witness the fastest growth.

Parkway MediCentre taps AeviceMD for home asthma monitoring

The bottle cap-sized device tracks a child’s lung sounds continuously at night.

UTI testing market to reach $78.9b by 2036 on antibiotic resistance, diagnostic demand

India and China are emerging as significant centres due ti high investment.

Japan pressed to act as childhood myopia progresses faster

Experts warn slow adoption could double severe retinal disease by 2050. 

Apheresis market to hit $4.4b by 2031 on autoimmune, surgical demand

Asia Pacific is estimated to record the highest CAGR.

Regional travel burdens push KPJ Perdana to expand locally

It is expected to improve access to specialist services within Kelantan.